Sebastiaan van Liempd
Papers
1
Total Citations
64
H-Index
1
About
Dr. Sebastiaan van Liempd is a distinguished bioanalytical scientist whose research centers on advancing drug discovery and pharmacokinetics through innovative assay development. His seminal work, "Development and Validation of a Higher-Throughput Equilibrium Dialysis Assay for Plasma Protein Binding" (2011, 64 citations), revolutionized the measurement of plasma protein binding—a critical parameter in drug efficacy and safety. By introducing a semiautomated, higher-throughput equilibrium dialysis method, Dr. van Liempd enabled researchers to process 32 PPB measurements per screen with triplicate incubations, dramatically increasing efficiency and reproducibility while maintaining flexibility for diverse compound libraries. This contribution has become a cornerstone in preclinical drug development, cited extensively for its practical impact on reducing bottlenecks in early-stage screening. His expertise in bioanalysis and method validation has facilitated more accurate predictions of drug behavior in vivo, accelerating the translation of candidates from bench to clinic. Dr. van Liempd’s work exemplifies how rigorous analytical innovation can streamline pharmaceutical research, making him a key figure in the field of drug metabolism and pharmacokinetics.
Research Focus
Key Achievements
Top Papers
- 1